Business · 22/03/2022Updated: 10/17/2026 · 1 min read
FDA Issues Emergency Use Authorization for COVID-19 Biological Product
Summary
The US Food and Drug Administration (FDA) has granted an Emergency Use Authorization (EUA) for a biological product developed by Eli Lilly and Company (Lilly) to combat COVID-19, following a public health emergency declaration by the Secretary of Health and Human Services (HHS) on March 27, 2020.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →